Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Medtronic updates on SynchroMed reduced battery performance

Medtronic has issued additional information to patients and physicians about the potential for reduced battery performance in a small percentage of its SynchroMed II Implantable Drug Infusion Pumps.

Medtronic’s analysis of the issue indicates that it is related to the formation of a film within the pump battery that reduces battery performance which leads to the sudden loss of therapy and the return of underlying symptoms and/or withdrawal symptoms.

Medtronic said patients receiving intrathecal baclofen therapy are at risk for baclofen withdrawal syndrome, which leads to a life-threatening condition if not treated quickly.

Medtronic encourages patients to carry their patient identification cards with them at all times and to contact their physicians if they experience a return of symptoms or hear a device alarm.

Medtronic is working to obtain US approval for a battery design change intended to prevent the issue from occurring in future pumps.